Mitch Ibach, OD, FAAO

A newer class of topical glaucoma therapy, Rho kinase inhibitors, works to lower intraocular pressure in patients with glaucoma via a novel mechanism. In this podcast, Mitch Ibach, OD, FAAO, of Vance Thompson Vision in Sioux Falls, SD, and Jessica Steen, OD, FAAO, of the Nova Southeastern University College of Optometry in Fort Lauderdale, FL, will discuss the mechanism of action of these agents, along with data supporting their use within the broader range of topical glaucoma therapies.

As new treatment options continue to enter the glaucoma space, clinicians can provide the best care to each individual patient.

Mitch Ibach, OD, FAOO, tells us about the current corneal cross-linking treatments, as well as those on the horizon.

Mitch Ibach, OD, FAAO, shares highlights from his VEW 2022 presentation, "Visual fields, a virtual reality."

This far-less-understood option can fill multiple needs for a practice.